Consensus or Controversy: Do Recent Advances Shift the Debate for the Use of Echocardiography Versus Cardiac Magnetic Resonance Imaging of the Right Ventricle in Pulmonary Arterial Hypertension?

Advances in Pulmonary Hypertension

¹ 

关键词: Cardiology;    Pediatrics;    WHO Group 1- Pulmonary Arterial Hypertension;    WHO Group 2- PH owing to left heart disease (left heart failure);    WHO Group 4;    Cardiac MRI;    Nuclear Scan (Ventilation/Perfusion Scan or V/Q scan);    Surgical Interventions;    Anatomy;    Physiology/Pathophysiology;    symptoms;    Research;    Exercise;    Idiopathic (Primary pulmonary hypertension);    Associated Diseases;    Patent Ductus Arteriosus;    Eisenmenger Syndrome;    diastolic dysfunction;    bronchiolitis obliterans;    Chronic thromboembolic pulmonary hypertension;    nitric oxide;    RV Size;    Indicators of diastolic dysfunction;    RV Function;    Non-invasive estimate of PVR;    Pulmonary vascular resistance;    pulmonary artery pressure;    Cardiac Output;    exercise hemodynamic testing;    vascular remodeling;    Preserved ejection fraction;    endothelial proliferation;    endothelial dysfunction;    tricuspid regurgitation;    Qualitative research;    Drug development;    clinical trial endpoints;    Observational Studies;    Education;    CME;    Classification;    Epidemiology;   

DOI  :  

学科分类：医学（综合）

来源: Pulmonary Hypertension Association

【 摘 要 】

Doppler echocardiography and 2D-TTE is frequently the first diagnostic test employed in the evaluation of patients with known or suspected PAH, in part because of its widespread availability, ease and speed of image acquisition, lack of ionizing radiation, and because patients with what may ultimately prove to be PAH are often initially referred for evaluation of unexplained dyspnea. Echocardiography also has the advantage of providing hemodynamic evaluation such as an estimate of PA pressures and LV filling pressure, and the ability to evaluate for valvular heart disease and LV systolic and diastolic dysfunction.4,11,12

【 授权许可】

All Rights reserved